Restenosis is a complex biological process. The promise of drug-eluting stents is that the stent scaffolding is designed to mitigate the mechanical components of the restenotic process, while the drug coating attacks the underlying biological mechanisms of restenosis.

Additional Metadata
Persistent URL hdl.handle.net/1765/112446
Citation
Serruys, P.W.J.C, & Veldhof, S. (2001). The multi-link TETRA D™ drug-eluting coronary stent system. In Handbook of Coronary Stents, Fourth Edition (pp. 322–325). Retrieved from http://hdl.handle.net/1765/112446